Kumanu Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series A1
- Financing Rounds
-
9
Kumanu General Information
Description
Developer of a well-being platform designed to address personal, social, and organizational determinants of health. The company's platform uses behavioral and data science to help people find purpose in life and connect their purpose to action which seamlessly integrates with programs, resources, and benefits, enabling users to generate powerful insights into life engagement and behavior patterns to guide their strategy.
Contact Information
Website
www.kumanu.comCorporate Office
- PO Box 3432
- Ann Arbor, MI 48106
- United States
Corporate Office
- PO Box 3432
- Ann Arbor, MI 48106
- United States
Kumanu Timeline
Kumanu Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kumanu Comparisons
Industry
Financing
Details
Kumanu Competitors (9)
One of Kumanu’s 9 competitors is WellRight, a Venture Capital-Backed company based in Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| WellRight | Venture Capital-Backed | Chicago, IL | ||||
| eMindful | Private Equity-Backed | Orlando, FL | ||||
| Heka (Business/Productivity Software) | Venture Capital-Backed | Willaston, United Kingdom | ||||
| Quantive (Business/Productivity Software) | Formerly VC-backed | Denver, CO | ||||
| Personify Health | Private Equity-Backed | Fresno, CA |
Kumanu Patents
Kumanu Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025099490-A2 | Compositions and treatments for fragile x syndrome and autism spectrum disorder | Inactive | 06-Nov-2023 | ||
| AU-2024377705-A1 | Compositions comprising a nnrti and uses thereof for treating autism, fragile x syndrome or behavioural disorders | Pending | 06-Nov-2023 | ||
| WO-2025099490-A3 | Compositions comprising a nnrti and uses thereof for treating autism, fragile x syndrome or behavioural disorders | Inactive | 06-Nov-2023 | ||
| WO-2025099486-A1 | Compositions comprising a nnrti and uses thereof for treating tcf4 mediated autism or pitt-hopkins syndrome | Inactive | 06-Nov-2023 | ||
| AU-2020263384-A1 | Electronic devices and methods for self-affirmation and development of purposeful behavior | Inactive | 24-Apr-2019 | G06F3/0482 |
Kumanu Signals
Kumanu Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kumanu FAQs
-
When was Kumanu founded?
Kumanu was founded in 2015.
-
Where is Kumanu headquartered?
Kumanu is headquartered in Ann Arbor, MI.
-
What is the size of Kumanu?
Kumanu has 20 total employees.
-
What industry is Kumanu in?
Kumanu’s primary industry is Business/Productivity Software.
-
Is Kumanu a private or public company?
Kumanu is a Private company.
-
What is the current valuation of Kumanu?
The current valuation of Kumanu is .
-
What is Kumanu’s current revenue?
The current revenue for Kumanu is .
-
How much funding has Kumanu raised over time?
Kumanu has raised $20.7M.
-
Who are Kumanu’s investors?
Quantum Ventures (Private Equity), ProMedica Health Systems, ProMedica Innovations, CVC JOOL Investors, and Michigan Angel Fund are 5 of 8 investors who have invested in Kumanu.
-
Who are Kumanu’s competitors?
WellRight, eMindful, Heka (Business/Productivity Software), Quantive (Business/Productivity Software), and Personify Health are some of the 9 competitors of Kumanu.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process